FH and atypical hemolytic-uremic syndrome: The model simulations, via reduction in FH and CD59, reflect the mechanistic basis of complement activation in diseases such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).